Omninvest Ltd Report issue

For profit Phase 4
Founded: Budapest Hungary (1995)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2007
NCT00778297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Omninvest Ltd. | Omninvest Vaccine Manufacturing, Researching and Trading Ltd.

Active Ingredients

Drugs in Phase 4 Trials (1)

fluoxetine (prozac) (8 trials)

Drugs in Other Trials (4)

fab-3511 (1 trial)

fab-6011 (2 trials)

fab-9011 (1 trial)

fluvalal (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 5